Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative Group.
Lopes LF, Macedo CR, Aguiar Sdos S, Barreto JH, Martins GE, Sonaglio V, Milone M, Lima ER, Almeida MT, Lopes PM, Watanabe FM, D'Andrea ML, Pianovski MA, Melaragno R, Vianna SM, Moreira ME, Bruniera P, de Oliveira CZ. Lopes LF, et al. Among authors: watanabe fm. J Clin Oncol. 2016 Feb 20;34(6):603-10. doi: 10.1200/JCO.2014.59.1420. Epub 2016 Jan 4. J Clin Oncol. 2016. PMID: 26729441
Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1.
Brunetto AL, Castillo LA, Petrilli AS, Macedo CD, Boldrini E, Costa C, Almeida MT, Kirst D, Rodriguez-Galindo C, Pereira WV, Watanabe FM, Pizza M, Benites E, Morais V, Gadelha A, Nakasato A, Abujamra AL, Gregianin LJ; Brazilian Collaborative On behalf of the Brazilian Collaborative Study Group of Ewing Family of Tumors EWING1 and the Brazilian Society of Pediatric Oncology SOBOPE. Brunetto AL, et al. Among authors: watanabe fm. Pediatr Blood Cancer. 2015 Oct;62(10):1747-53. doi: 10.1002/pbc.25562. Epub 2015 Apr 27. Pediatr Blood Cancer. 2015. PMID: 25917418 Clinical Trial.
Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation.
Figueiredo BC, Sandrini R, Zambetti GP, Pereira RM, Cheng C, Liu W, Lacerda L, Pianovski MA, Michalkiewicz E, Jenkins J, Rodriguez-Galindo C, Mastellaro MJ, Vianna S, Watanabe F, Sandrini F, Arram SB, Boffetta P, Ribeiro RC. Figueiredo BC, et al. J Med Genet. 2006 Jan;43(1):91-6. doi: 10.1136/jmg.2004.030551. Epub 2005 Jul 20. J Med Genet. 2006. PMID: 16033918 Free PMC article.
Neuroblastoma in southern Brazil: an 11-year study.
Parise IZ, Haddad BR, Cavalli LR, Pianovski MA, Maggio EM, Parise GA, Watanabe FM, Ioshii SO, Rone JD, Caleffe LG, Odone Filho V, Figueiredo BC. Parise IZ, et al. Among authors: watanabe fm. J Pediatr Hematol Oncol. 2006 Feb;28(2):82-7. doi: 10.1097/01.mph.0000199601.35010.52. J Pediatr Hematol Oncol. 2006. PMID: 16462579
Penetrance of the TP53 R337H Mutation and Pediatric Adrenocortical Carcinoma Incidence Associated with Environmental Influences in a 12-Year Observational Cohort in Southern Brazil.
Costa TEJ, Gerber VKQ, Ibañez HC, Melanda VS, Parise IZS, Watanabe FM, Pianovski MAD, Fiori CMCM, Fabro ALMR, Silva DBD, Andrade DP, Komechen H, Mendes MC, Carboni E, Kuczynski AP, Souza EN, Paraizo MM, Ibañez MVC, Castilho LM, Cruz AF, Maia TFD, Machado-Souza C, Rosati R, Oliveira CS, Parise GA, Passos JDC, Barbosa JRS, Figueiredo MMO, Lima L, Tormen T, Sabbaga CC, Ávilla SGA, Grisa L, Aranha A, Tosin KCF, Ogradowski KRP, Lima G, Legal EF, Anegawa TH, Mazzuco TL, Grion AL, Balbinotti JHG, Dammski KL, Melo RG, Filho NK, Custódio G, Figueiredo BC. Costa TEJ, et al. Among authors: watanabe fm. Cancers (Basel). 2019 Nov 16;11(11):1804. doi: 10.3390/cancers11111804. Cancers (Basel). 2019. PMID: 31744167 Free PMC article.
Newborn Screening for the Detection of the TP53 R337H Variant and Surveillance for Early Diagnosis of Pediatric Adrenocortical Tumors: Lessons Learned and Way Forward.
Tosin KCF, Legal EF, Pianovski MAD, Ibañez HC, Custódio G, Carvalho DS, Figueiredo MMO, Hoffmann Filho A, Fiori CMCM, Rodrigues ALM, Mello RG, Ogradowski KRP, Parise IZS, Costa TEJ, Melanda VS, Watanabe FM, Silva DB, Komechen H, Laureano HA, Carboni EK, Kuczynski AP, Luiz GCF, Lima L, Tormen T, Gerber VKQ, Anegawa TH, Avilla SGA, Tenório RB, Mendes EL, Fachin Donin RD, Souza J, Kozak VN, Oliveira GS, Souza DC, Gomy I, Teixeira VB, Borba HHL, Kiesel Filho N, Parise GA, Ribeiro RC, Figueiredo BC. Tosin KCF, et al. Among authors: watanabe fm. Cancers (Basel). 2021 Dec 3;13(23):6111. doi: 10.3390/cancers13236111. Cancers (Basel). 2021. PMID: 34885220 Free PMC article.
Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.
Pritchard-Jones K, Bergeron C, de Camargo B, van den Heuvel-Eibrink MM, Acha T, Godzinski J, Oldenburger F, Boccon-Gibod L, Leuschner I, Vujanic G, Sandstedt B, de Kraker J, van Tinteren H, Graf N; SIOP Renal Tumours Study Group. Pritchard-Jones K, et al. Lancet. 2015 Sep 19;386(9999):1156-64. doi: 10.1016/S0140-6736(14)62395-3. Epub 2015 Jul 9. Lancet. 2015. PMID: 26164096 Free article. Clinical Trial.